BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3539468)

  • 1. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
    Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
    Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
    Di Paolo N; De Mia M; Gaggiotti E
    Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic use of metadoxine in alcohol-related mental and behavioral disorders].
    Carboni MA; Corsa R
    Clin Ter; 1987 Dec; 123(6):469-73. PubMed ID: 2972505
    [No Abstract]   [Full Text] [Related]  

  • 5. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.
    Caballería J; Parés A; Brú C; Mercader J; García Plaza A; Caballería L; Clemente G; Rodrigo L; Rodés J
    J Hepatol; 1998 Jan; 28(1):54-60. PubMed ID: 9537864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metadoxine in the control of oxidative stress caused by acute and chronic ethanol poisoning].
    Calabrese V; de Bernardis E; Rizza V
    Boll Soc Ital Biol Sper; 1986 Nov; 62(11):1357-63. PubMed ID: 3828134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study].
    Mao YM; Zeng MD; Li YM; Wang BY; Shang J; Shi RH; Liu JY; Lu LG; Cao AP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):213-6. PubMed ID: 19335986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
    Váli L; Blázovics A; Fehér J
    Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
    Stefanini GF; Addolorato G; Caputo F; Bernardi M; Gasbarrini G
    J Hepatol; 1999 Apr; 30(4):739-40. PubMed ID: 10207820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Steatosis and fibrosis: first stage of liver damage induced by chronic alcoholism. Our experience in 100 cases].
    Mancinella A
    Clin Ter; 1991 Apr; 137(1):29-38. PubMed ID: 1828726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
    Ki SH; Choi JH; Kim CW; Kim SG
    Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic abstinence syndrome: short-term treatment with metadoxine.
    Bono G; Sinforiani E; Merlo P; Belloni G; Soldati M; Gelso E
    Int J Clin Pharmacol Res; 1991; 11(1):35-40. PubMed ID: 1678735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
    Pal'tsev AI; Sharapov IV; Gorbunova EN; Khomchenko TN; Kurganova IV; Soldatova GS; Eremina AA; Nikolaev IuA
    Eksp Klin Gastroenterol; 2009; (8):19-25. PubMed ID: 20469674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study.
    Shpilenya LS; Muzychenko AP; Gasbarrini G; Addolorato G
    Alcohol Clin Exp Res; 2002 Mar; 26(3):340-6. PubMed ID: 11923586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of metadoxine on main biohumoral changes induced by chronic alcoholism].
    Corsini G; Gelso E; Giuliano G
    Clin Ter; 1992 Mar; 140(3):251-7. PubMed ID: 1568369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease.
    Leggio L; Kenna GA; Ferrulli A; Zywiak WH; Caputo F; Swift RM; Addolorato G
    Hum Psychopharmacol; 2011 Dec; 26(8):554-9. PubMed ID: 22095793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
    Ghittoni S; Orsucci O; Saviozzi A; Simonini P
    Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metadoxyl in combined treatment of alcohol damage to the liver].
    Vedrova NN; Gnezdilova NIu
    Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
    Verzetti G; Emanuelli G; Montagnani M
    Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.